Business Context and Reporting Period
Company: Teradyne, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: April 4, 2010
Business Overview: Teradyne is a leading global supplier of automatic test equipment, operating through two primary segments: Semiconductor Test and Systems Test Group (which includes military/aerospace, hard disk drive, circuit-board, and automotive diagnostic systems). The company serves a broad customer base including integrated device manufacturers, outsourced test providers, and automotive companies.
Key Financial Metrics
| Metric (in thousands) | Q1 2010 | Q1 2009 |
|---|---|---|
| Total Net Revenues | $329,623 | $120,608 |
| Gross Profit | $173,544 | $33,360 |
| Gross Margin | 52.6% | 27.7% |
| Operating Income | $60,001 | ($93,415) |
| Net Income | $50,100 | ($90,668) |
| Diluted EPS | $0.24 | ($0.53) |
| Cash from Operations | $26,687 | ($65,583) |
| Cash & Equivalents (End of Period) | $342,012 | $279,057 |
| Total Debt (Current + Long-term) | $144,576 | $143,257 |
Material Changes vs. Prior Period
- Revenue Surge: Total net revenues increased by $209.0 million (173%) compared to Q1 2009. This was driven almost entirely by the Semiconductor Test segment, which saw revenue jump from $78.5 million to $289.7 million (269% increase) due to higher sales of System-on-a-Chip products.
- Profitability Turnaround: The company swung from a net loss of $90.7 million in Q1 2009 to a net income of $50.1 million in Q1 2010. Operating income improved by $153.4 million.
- Gross Margin Expansion: Gross margin improved by 24.9 percentage points to 52.6%, attributed to higher sales volume, favorable product mix, and significantly lower inventory provisions ($1.4 million in Q1 2010 vs. $8.6 million in Q1 2009).
- Restructuring Costs: Restructuring and other charges dropped significantly to $1.3 million in Q1 2010 from $16.0 million in Q1 2009, reflecting the completion of major headcount reductions initiated in the prior year.
- Cash Flow: Operating cash flow turned positive at $26.7 million, reversing a $65.6 million outflow in the prior year period. However, investing activities consumed $105.8 million, primarily due to $95.4 million in purchases of marketable securities.
Guidance, Outlook, and Risks
- Management Commentary: Management notes continued improvement in the business, particularly in Semiconductor Test. They attribute success to cost-cutting measures implemented during the downturn and strategic acquisitions (Nextest and Eagle Test). The company believes its current cost structure allows for significantly higher profitability at comparable revenue levels than in the past.
- Book-to-Bill Ratio: The total company book-to-bill ratio was 1.6 in Q1 2010, up from 1.1 in Q1 2009, indicating strong order momentum.
- Convertible Notes: The company has $190 million in 4.50% convertible senior notes due in 2014. During Q1 2010, conditions were met allowing holders to convert notes prior to maturity, though no conversions had occurred as of May 14, 2010.
- Risks and Contingencies:
- Cyclicality: Sales are highly dependent on cyclical trends in the semiconductor and automotive industries.
- Inventory: While provisions have decreased, the company maintains $131.9 million in inventory reserves for items written down or written off.
- Valuation Allowance: The company maintains a valuation allowance for deferred tax assets in the U.S. and Singapore due to uncertainty regarding realization, which may limit future tax benefits until sustained profitability is demonstrated.
Investor Verification Checklist
- Sustainability of Semiconductor Demand: Verify if the 269% revenue growth in the Semiconductor Test segment is sustainable or driven by specific one-time large orders.
- Inventory Health: Review the $131.9 million in inventory reserves and the company's ability to liquidate or utilize excess inventory without further write-downs.
- Convertible Note Conversion Risk: Monitor the stock price relative to the conversion price ($5.48) to assess the likelihood of dilution from the $190 million convertible notes.
- Deferred Revenue: Note the significant decrease in deferred revenue ($35.4 million drop in operating cash flow), which may indicate a shift in the timing of future revenue recognition.
- Restructuring Accruals: Confirm the remaining $11.3 million in restructuring accruals (severance and facility exit costs) and the timeline for their payout.